• Home
  • Search Results

Search Results

2462 studies match your search
By physician referral or invitation only

Nasal markers in allergy immunotherapy

We are looking at nasal markers in patients undergoing treatment of allergies to see if these markers can help predict who will respond successfully to treatment.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Allergy
  • Ear, Nose, and Throat
Visit Location
100% Remote (online, phone, text)
By physician referral or invitation only

Patient experiences and perceptions in bleeding disorders

The purpose of this study is to better understand the experiences of individuals who have been diagnosed with certain bleeding disorders.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Blood Conditions
Visit Location
100% Remote (online, phone, text)
By physician referral or invitation only

Treatment Use for ACL Injury Study

Compare the use of ACL reconstruction and physical therapy in Black and White people and people with different socioeconomic status after ACL injury. Black people and people with lower socioeconomic status are at higher risk of long-term disability related to arthritis that is common after ACL injury. The above treatments may reduce long-term disability, but use of these treatments may be different across racial and socioeconomic groups. The project will also look at factors related to treatment use in Black people with ACL injury. Identifying these factors will help us figure out how to improve treatment use in Black people, who are often underrepresented in clinical research. *This study is a collaboration with the UNC Sports Medicine Institute*

Age & Gender
  • 15 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Injury/Injury Prevention
Visit Location
100% Remote (online, phone, text)
By physician referral or invitation only

Bias of TikTok recommender system

Identify the bias and algorithms of TikTok's recommender system and to see how the bias of recommendation algorithms affects user experience.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Healthy Volunteer or General Population
  • UNC Students (undergrad, grad, professional)
Visit Location
100% Remote (online, phone, text)
By physician referral or invitation only

Lumosa Therapeutibs BRIGHT AIS trial

This study will evaluate the safety and effectiveness of a new intravenous (IV) medication (LT3001) for adult patients who have had a stroke. This new medication is designed to restore blood flow to the area of the brain affected, and reduce inflammation in the brain. Patients who agree to be in this study will receive 6 doses of the IV study drug while in the hospital. Patients will have extra labs drawn, head imaging studies and will be followed by the study team for 90 days after their hospital admission.

Age & Gender
  • 18 years ~ 90 years
  • Male, Female, Gender Inclusive
Study Interest
  • Brain, Head, Nervous System
Visit Location
100% Remote (online, phone, text)
By physician referral or invitation only

Preferences for Domestic and International Climate Policy

The goal of this study is to explore factors that influence public support for both domestic and international efforts to address climate change.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Environment
  • UNC Students (undergrad, grad, professional)
Visit Location
100% Remote (online, phone, text)
By physician referral or invitation only

Harnessing cultural and emotional intelligence to promote workplace diversity, equity, and inclusion

This study explores the role of emotional and cultural intelligence in enhancing diversity, equity and inclusion (DEI) within organizations. This study proposes conducting in-depth interviews with communications and DEI professionals to refine a training slide deck that could be used in organizations to increase awareness about emotional intelligence and its importance to organizational culture.

Age & Gender
  • 21 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Opinions and Perceptions
Visit Location
100% Remote (online, phone, text)
By physician referral or invitation only

A Feasibility and Randomized Phase 2/3 Study of the VEFGR2/MET Inhibitor Cabozantinib in Combination with Cytotoxic Chemotherapy for Newly Diagnosed Osteosarcoma

Osteosarcoma is the most common primary bone malignancy of childhood and adolescence. Survival rates for patients with standard risk (localized, resectable primary tumors) and high-risk disease (presence of metastases, unresectable or primary pelvic tumors) are 70% and 20-30%, respectively, and have remained unchanged for several decades despite numerous attempts to augment standard therapies. Multi-targeted receptor tyrosine kinase inhibitors (MTKIs), such as cabozantinib, can target signaling pathways that are known to be altered in osteosarcoma. Several MTKIs including cabozantinib have recently shown clinical evidence of activity in prospective studies for both pediatric and adult patients with advanced osteosarcoma. Furthermore, feasibility of administering MTKIs in combination with cytotoxic chemotherapy has previously been shown in patients with AML, hepatocellular carcinoma, and soft tissue sarcomas. Osteosarcoma is the most common primary bone malignancy of childhood and adolescence. Survival rates for patients with standard risk (localized, resectable primary tumors) and high-risk disease (presence of metastases, unresectable or primary pelvic tumors) are 70% and 20-30%, respectively, and have remained unchanged for several decades

Age & Gender
  • 0 days ~ 40 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Pediatric Cancers, Sarcoma (bone and soft tissue))
Visit Location
100% Remote (online, phone, text)
By physician referral or invitation only

HEALEY ALS Platform Trial

The purpose of the HEALEY ALS Platform Trial is to develop and administer various clinical trials under different regimens with ALS to provide multiple treatment options for patients with ALS.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Brain, Head, Nervous System
  • Chronic Conditions
Visit Location
100% Remote (online, phone, text)
By physician referral or invitation only

Influence of design elements and disclaimers on user assessment of social media health and political content

This study will test the effect and effectiveness of labels on political ads that disclose the use of generative AI. Governments and some internet platforms have begun requiring that political advertisers include these disclaimers, however we lack experimental study of the effect and effectiveness of these disclaimers.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Healthy Volunteer or General Population
Visit Location
100% Remote (online, phone, text)
Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research